National Screening Advisory Committee
The National Screening Advisory Committee (NSAC) provides high level strategic governance and leadership related to national population based health and disability screening programmes. NSAC reports to the Ministry of Health's Chief Medical Officer and the Deputy Director-General, Population Health and Prevention.
Role of NSAC
The role of NSAC is to:
- provide leadership and strategic direction for national population based screening programmes
- make evidence based recommendations about the case for implementing new population screening programmes, including consideration of their effectiveness, feasibility, likely harms and benefits, value for money, and impact on the health system
- identify screening technologies of proven effectiveness which require central agency led and well-managed implementation as national screening or quality improvement programmes
- advise whether to continue, modify or withdraw existing population screening programmes, particularly those programmes inadequately evaluated or of doubtful effectiveness, quality, or value
- consider and endorse major changes within current screening programmes as raised by NSU advisory groups
- consult and liaise with clinical leaders and experts on screening to obtain sound advice, referring appropriate issues for further research and commissioning evidence based review as NSU resources allow
- undertake a horizon scanning function to provide guidance on emerging and future technologies suitable for population screening programmes.
To find out more about NSAC read the committee's terms of reference (doc, 32 KB)
Membership
The Committee is multidisciplinary with members chosen for their linkages to other health or academic groups as well as their individual skills, for example, expertise in public health, screening programmes, epidemiology, ethics and health economics.
Current members
|
Pania Coote (Chair) |
Director, AwhiMai Consultancy, Māori Health and Strategy |
|
Dr Jane O'Hallahan (Deputy Chair) |
Clinical Director, National Screening Unit, Ministry of Health |
|
Dr Carol Atmore |
Head of Department, Department of General Practice and Rural Health, Dunedin School of Medicine, University of Otago |
|
Dr Karen Bartholomew |
Director, Health Outcomes, Planning Funding and Outcomes, Waitemata DHB and Auckland DHB |
|
Professor Barry Borman |
Associate Director, Professor in Epidemiology, Centre for Public Health Research, Massey University |
|
Sheila Beckers |
Consumer Representative |
|
Stephanie Chapman |
Acting Group Manager, National Screening Unit, Ministry of Health |
|
Professor Mark Elwood |
Professor of Cancer Epidemiology, School of Population Health, The University of Auckland |
|
Dr Gary Jackson |
Director of Population Health, Counties Manukau DHB |
|
Dr Nicholas Jones |
Director of Public Health, Public Health Agency, Manatū Hauora |
|
Dr Rawiri McKree-Jansen |
Chief Medical Advisor, Te Aka Whai Ora |
|
Professor John McMillan |
Bioethics Centre, Division of Health Sciences, University of Otago |
|
Dr Katherine Neas |
National Clinical Director, Genetic Health Service NZ |
|
Dr Nina Scott |
Hei Āhuru Mōwai, National Māori Cancer Leadership Aotearoa |
|
Dr Pat Tuohy |
Community Paediatrician, Hutt Valley DHB |
In this section
-
Minutes of meetings held outlining the discussions on the National Screening Unit’s strategic direction, programme initiatives and also the committee’s recommendations.
-
National Screening Advisory Committee publications produced between 2007 and 2010
Page last updated: 19 December 2018